Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer's ...
A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the ...
"This groundbreaking study has the potential to revolutionize PTSD treatment by integrating sound and music-based interventions with established cognitive therapies," said Dr. Rebecca Knowles ...